% alzhub.org library filter % Source: https://alzhub.org/research?author=Li+Y&institution=I45129253 % 5 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{morenasrodriguez2022-35305339, author = {Morenas-Rodríguez, E. and Li, Y. and Nuscher, B. and Franzmeier, N. and Xiong, C. and Suárez-Calvet, M. and Fagan, A. M. and Schultz, S. and others}, title = {{Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study}}, journal = {The Lancet. Neurology}, year = {2022}, doi = {10.1016/s1474-4422(22)00027-8}, pmid = {35305339}, url = {https://doi.org/10.1016/s1474-4422(22)00027-8} } @article{josephmathurin2022-36151869, author = {Joseph-Mathurin, N. and Llibre-Guerra, J. J. and Li, Y. and McCullough, A. A. and Hofmann, C. and Wojtowicz, J. and Park, E. and Wang, G. and others}, title = {{Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease}}, journal = {Annals of neurology}, year = {2022}, doi = {10.1002/ana.26511}, pmid = {36151869}, url = {https://doi.org/10.1002/ana.26511} } @article{llibreguerra2019-31825500, author = {Llibre-Guerra, J. J. and Li, Y. and Schindler, S. E. and Gordon, B. A. and Fagan, A. M. and Morris, J. C. and Benzinger, T. L. S. and Hassenstab, J. and others}, title = {{Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease}}, journal = {JAMA network open}, year = {2019}, doi = {10.1001/jamanetworkopen.2019.17126}, pmid = {31825500}, url = {https://doi.org/10.1001/jamanetworkopen.2019.17126} } @article{fagan2021-34302786, author = {Fagan, A. M. and Henson, R. L. and Li, Y. and Boerwinkle, A. H. and Xiong, C. and Bateman, R. J. and Goate, A. and Ances, B. M. and others}, title = {{Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study}}, journal = {The Lancet. Neurology}, year = {2021}, doi = {10.1016/s1474-4422(21)00139-3}, pmid = {34302786}, url = {https://doi.org/10.1016/s1474-4422(21)00139-3} } @article{xia2025-40730714, author = {Xia, X. and Aye, S. and Frisell, O. and Aho, E. and Handels, R. and Li, Y. and Wimo, A. and Winblad, B. and Eriksdotter, M. and Skillbäck, T. B. and Kern, S. and Zetterberg, H. and others}, title = {{The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer's Disease in Sweden}}, journal = {PharmacoEconomics}, year = {2025}, doi = {10.1007/s40273-025-01527-7}, pmid = {40730714}, url = {https://doi.org/10.1007/s40273-025-01527-7} }